Because most therapeutic proteins suffer from poor pharmaceutical properties, a key element for the satisfactory development of novel protein drugs is to fully measure their half-life and pharmacodynamic behavior before performing clinical trials. Learn more about Animal Model Development for Half-life Assay Service: https://half-life-extension.cr....eative-biolabs.com/a
お気に入り
コメント
シェア
